ATE429640T1 - Diagnostischer assay zur bestimmung einer zellvermittelten immunantwort - Google Patents

Diagnostischer assay zur bestimmung einer zellvermittelten immunantwort

Info

Publication number
ATE429640T1
ATE429640T1 AT03769070T AT03769070T ATE429640T1 AT E429640 T1 ATE429640 T1 AT E429640T1 AT 03769070 T AT03769070 T AT 03769070T AT 03769070 T AT03769070 T AT 03769070T AT E429640 T1 ATE429640 T1 AT E429640T1
Authority
AT
Austria
Prior art keywords
assay
cell
mediated immune
immune response
diagnostic assay
Prior art date
Application number
AT03769070T
Other languages
English (en)
Inventor
James Stuart Rothel
Steven Paul Wild
Angela Cosgriff
Original Assignee
Cellestis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellestis Ltd filed Critical Cellestis Ltd
Application granted granted Critical
Publication of ATE429640T1 publication Critical patent/ATE429640T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Holo Graphy (AREA)
  • Inspection Of Paper Currency And Valuable Securities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03769070T 2002-11-08 2003-11-06 Diagnostischer assay zur bestimmung einer zellvermittelten immunantwort ATE429640T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002952548A AU2002952548A0 (en) 2002-11-08 2002-11-08 Diagnostic assay
PCT/AU2003/001464 WO2004042396A1 (en) 2002-11-08 2003-11-06 Diagnostic assay for measuring a cell mediated immune response

Publications (1)

Publication Number Publication Date
ATE429640T1 true ATE429640T1 (de) 2009-05-15

Family

ID=28795938

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03769070T ATE429640T1 (de) 2002-11-08 2003-11-06 Diagnostischer assay zur bestimmung einer zellvermittelten immunantwort

Country Status (8)

Country Link
US (1) US7608392B2 (de)
EP (1) EP1561106B1 (de)
JP (1) JP4502814B2 (de)
AT (1) ATE429640T1 (de)
AU (1) AU2002952548A0 (de)
CA (1) CA2504829C (de)
DE (1) DE60327354D1 (de)
WO (1) WO2004042396A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118884A1 (en) * 2004-05-28 2005-12-15 The United States Of America As Represented By The Secretary Of The Navy A method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
JP2006189338A (ja) * 2005-01-06 2006-07-20 Sekisui Chem Co Ltd 炎症性腸疾患の治療前効果予測方法並びに治療効果の判定方法
GB0616238D0 (en) * 2006-08-15 2006-09-27 Inst Animal Health Ltd Diagnostic Test
ATE504000T1 (de) 2006-09-05 2011-04-15 Hvidovre Hospital Auf ip-10 basierende immunologische überwachung
WO2008147426A2 (en) * 2006-10-04 2008-12-04 The Brigham And Women's Hospital, Inc. Methods and compositions for immunomodulation
EP2132569B1 (de) * 2007-03-16 2015-10-28 Cellestis Limited Assay für zellvermittelte immunantwort und kits dafür
EP2137297A4 (de) * 2007-04-11 2010-04-14 Roger Deutsch Verfahhren zur diagnostizierung biologischer proben mit stammzellen
US20090062237A1 (en) * 2007-06-15 2009-03-05 Mayo Foundation For Medical Education And Research Evaluating immune competence
US20100221755A1 (en) * 2007-06-15 2010-09-02 University Of Rochester Use of antibody secreting cell elispot to assess antibody responses following antigen exposure
EP2310850B1 (de) * 2008-07-25 2018-10-17 Cellestis Limited Diagnoseverfahren
MX346450B (es) 2008-11-30 2017-03-17 Immusant Inc * Composiciones y métodos para el tratamiento de la enfermedad celíaca.
WO2010144794A1 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Baculovirus-expressed fusion polypeptide vaccines with enhanced immunogenicity and uses thereof
CN102573883A (zh) 2009-06-12 2012-07-11 疫苗技术公司 用于促进细胞-介导的免疫应答的方法和组合物
US9459253B2 (en) * 2009-12-23 2016-10-04 Cellestis Limited Assay for measuring cell-mediated immunoresponsiveness
US8771967B2 (en) 2010-11-16 2014-07-08 The Board Of Trustees Of The Leland Stanford Junior University Immunomodulation of functional T cell assays for diagnosis of infectious or autoimmune disorders
CN103620051A (zh) * 2011-04-29 2014-03-05 塞尔雷斯蒂斯有限公司 细胞介导的免疫应答力试验
US9678071B2 (en) 2012-01-12 2017-06-13 Mayo Foundation For Medical Education And Research Detecting latent tuberculosis infections
IN2014DN08394A (de) * 2012-03-23 2015-05-08 Esteve Labor Dr
CN102707052B (zh) * 2012-05-11 2015-03-11 中国农业科学院北京畜牧兽医研究所 含重组蛋白混合物的牛结核病检测试剂
CN110118871A (zh) 2012-12-28 2019-08-13 塞尔雷斯蒂斯有限公司 细胞介导的免疫应答试验
CA2900008C (en) 2013-02-07 2025-10-07 Children's Medical Center Corporation PROTEIN ANTIGENS THAT CONFER PROTECTION AGAINST COLONIZATION AND/OR PNEUMOCOCCAL DISEASE
US10401360B2 (en) 2013-04-29 2019-09-03 Mayo Foundation For Medical Education And Research Flow cytometry assay methods
CA2923822A1 (en) 2013-09-10 2015-03-19 Immusant, Inc. Dosage of a gluten peptide composition
CN103604933A (zh) * 2013-11-27 2014-02-26 华中科技大学同济医学院附属同济医院 基于抗原特异性TNF-α-ELISA检测活动性结核病的试剂盒及其应用
CA2962933A1 (en) 2014-09-29 2016-04-07 Immusant, Inc. Use of hla genetic status to assess or select treatment of celiac disease
KR20240045370A (ko) 2014-10-23 2024-04-05 퀴아젠 사이언시스, 엘엘씨 펩티드 조성물 및 그의 용도
US10654923B2 (en) 2015-12-28 2020-05-19 Mayo Foundation For Medical Education And Research Methods for treating medical conditions by anti-type 2 therapy
KR20170110297A (ko) * 2016-03-23 2017-10-11 온틀협동조합 천연물 소재의 면역증강 검사법 및 상기 검사법을 활용한 맞춤형 식단 제공방법
KR101777252B1 (ko) 2016-07-07 2017-09-12 대한민국(농림축산식품부 농림축산검역본부장) T 세포의 prrsv 증식 억제능 평가 방법
KR101777256B1 (ko) 2016-07-07 2017-09-12 대한민국(농림축산식품부 농림축산검역본부장) T 세포의 병원체 감염 세포 독성능 평가 방법
ES2950436T3 (es) 2016-12-14 2023-10-10 Becton Dickinson Co Métodos y composiciones para obtener una valoración de tuberculosis en un sujeto
WO2020014703A1 (en) * 2018-07-13 2020-01-16 Excision Biotherapeutics, Inc. Detection of bacterial proteins/immunoglobulins for gene editing therapy
CN120795059A (zh) 2018-08-27 2025-10-17 瑞泽恩制药公司 拉曼光谱在下游纯化中的应用
EP4103232A4 (de) * 2020-02-14 2025-03-26 Epivax, Inc. Regulatorische t-zell-epitope und detolerierte sars-cov-2-antigene
EP4179328A2 (de) * 2020-07-10 2023-05-17 Covid Diagnostics Ltd. Zusammensetzungen, verfahren und systeme zum nachweis einer immunreaktion
CN113466000A (zh) * 2021-05-12 2021-10-01 广州医科大学附属肿瘤医院 基于多维度纯化富集技术的恶性胸水检测方法
US20250354980A1 (en) * 2022-06-09 2025-11-20 The Regents Of The University Of California Lymphocyte stimulation assay to quantify immune responses

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
EP0296158B1 (de) * 1986-03-06 1992-06-17 Commonwealth Scientific And Industrial Research Organisation In-vitro-testverfahren zum nachweis zellulärer immunresponsen
FR2615622B1 (fr) * 1987-05-19 1994-05-06 Ire Medgenix Sa Dosage plasmatique de monokines
US5693500A (en) * 1988-03-31 1997-12-02 Commonwealth Scientific And Industrial Research Organisation Diagnosis of Mycobacterium bovis infection
FR2645878B1 (fr) * 1989-04-17 1994-02-25 Institut Nal Sante Recherc Medic Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes
US6410252B1 (en) * 1995-12-22 2002-06-25 Case Western Reserve University Methods for measuring T cell cytokines
US5885529A (en) 1996-06-28 1999-03-23 Dpc Cirrus, Inc. Automated immunoassay analyzer
DE19835721A1 (de) * 1998-08-07 2000-02-10 Edi Experimentelle & Diagnosti Verfahren zur Bestimmung der Immunabwehr des Blutes sowie Testkit hierfür und Verwendung eines geeigneten Spritzenzylinders

Also Published As

Publication number Publication date
JP2006506609A (ja) 2006-02-23
EP1561106B1 (de) 2009-04-22
WO2004042396A1 (en) 2004-05-21
JP4502814B2 (ja) 2010-07-14
CA2504829A1 (en) 2004-05-21
AU2002952548A0 (en) 2002-11-21
EP1561106A1 (de) 2005-08-10
EP1561106A4 (de) 2006-12-27
US20050014205A1 (en) 2005-01-20
US7608392B2 (en) 2009-10-27
CA2504829C (en) 2013-01-22
DE60327354D1 (de) 2009-06-04

Similar Documents

Publication Publication Date Title
DE60327354D1 (de) Diagnostischer assay zur bestimmung einer zellvermittelten immunantwort
IN2015DN03125A (de)
Segal et al. Salivary diagnostics: enhancing disease detection and making medicine better
TW200600055A (en) Method of manufacturing integrated biosensors
TW200600060A (en) Apparatus for the manufacture of medical devices
JP5311439B2 (ja) 皮膚の状態を評価する方法及びその用途
DE60136335D1 (de) Parallele genotypisierung mehrerer patientenproben
GB2374929A (en) Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart
WO2000051055A3 (en) Method and apparatus for monitoring therapy effectiveness
EP2520935A3 (de) Organspezifische Proteine und Verfahren zu deren Verwendung
DE602004017201D1 (de) Nachweis einer histonmodifikation in zellfreien nukleosomen
Gupta et al. Proteomics–the research frontier in periodontics
Hanås et al. Influence of clinical setting and cat characteristics on indirectly measured blood pressure and pulse rate in healthy Birman, Norwegian Forest, and Domestic Shorthair cats
Dewan et al. Recent advancements and applications of nanosensors in oral health: revolutionizing diagnosis and treatment
ATE318930T1 (de) Nukleinsäuresonden zur detektion von candida- spezies
Radu et al. Characteristics of Haematological Parameters for Carp Culture and Koi (Cyprinus carpio Linneaus, 1758) Reared in an Intensive System.
BRPI0406680A (pt) Métodos para selecionar um animal para ter propriedades desejadas genotìpicas ou fenotìpicas em potencial, para modular a trascrição de mrna de um gene igf2 em uma célula ou organismo provido com referido gene e para identificar um composto, composto, composição farmacêutica, e, uso de um composto
Cacciapuoti et al. Effects of dietary intervention on nutritional status in elderly individuals with chronic kidney disease
ATE352039T1 (de) Verfahren zur bestimmung der aktivität von thymidinkinase-1 und dessen verwendung
DE69531505D1 (de) Verfahren zur zellerkennung
WO2010108245A3 (pt) Uso de antígenos de leishmania em método diagnóstico, vacina e terapia para leishmaniose
DE50210764D1 (de) Testsystem zur bestimmung von gentoxizitäten
Thomas Nonhuman paleopathology
Sun et al. pawH: Colorimetric pH-Sensing Toys for Non-Invasive Pet Health Monitoring
DE602006015221D1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1561106

Country of ref document: EP